FindMyKOL
Clinical trialNCT03382834CompletedPhase 2Interventional

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment31HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study evaluated the effects of tamoxifen exposure in combination with vorinostat on viral reactivation among HIV-1 infected post-menopausal women with virologic suppression on antiretroviral therapy (ART), when compared to vorinostat alone.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Puerto Rico Aids Clinical Trials Unit Crs

    San Juan, Puerto Rico

United States
  • Alabama Crs

    Birmingham, Alabama, United States

  • Ucla Care Center Crs

    Los Angeles, California, United States

  • Ucsf Hiv/aids Crs

    San Francisco, California, United States

  • Harbor-Ucla Crs

    Torrance, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • Whitman-Walker Health Crs

    Washington D.C., District of Columbia, United States

  • the Ponce de Leon Center Crs

    Atlanta, Georgia, United States

  • Northwestern University Crs

    Chicago, Illinois, United States

  • Massachusetts General Hospital Crs (mgh Crs)

    Boston, Massachusetts, United States

  • New Jersey Medical School Clinical Research Center Crs

    Newark, New Jersey, United States

  • Chapel Hill Crs

    Chapel Hill, North Carolina, United States

  • Greensboro Crs

    Greensboro, North Carolina, United States

  • Cincinnati Clinical Research Site

    Cincinnati, Ohio, United States

  • Penn Therapeutics, Crs

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Antiretroviral drugsTamoxifen →Vorinostat →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Apr 2018
Primary completion
4 Dec 2018
Completion
27 Jul 2023
Last update posted
3 Jul 2024
Registered enrollment
31
Registry id
NCT03382834

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.